Tag Archive for: board appointment

Commit Biologics appoints accomplished R&D executive, Dr Janine Schuurman, to its Board of Directors

/in

Former senior vice president of antibody research at Genmab who has co-invented numerous FDA-approved therapeutic antibodies and as well as its DuoBody® bi-specific antibody platform. Brings decades of experience in developing strong pipelines of antibody-based drugs from platforms, growing scientific teams and managing partnerships with Pharma companies Appointment comes as Commit looks to progress towards […]

Read more

Novo Holdings leads $105 million financing of Magenta Medical to support FDA approval for world’s smallest heart pump

/in

Funds will be used to advance Magenta’s US clinical programs to support the FDA’s approval of the Elevate™ System, the world’s smallest heart pump Eric Snyder, Partner, Venture Investments, Novo Holdings will join Magenta Medical Board of Directors Boston, US, 23 July 2024 – Novo Holdings, a leading life science investor, today announces that it has […]

Read more

AMSilk strengthens management team with key hires of Ralph Fraundorfer and Ctibor Kohutovic to Management Board

/in

Neuried, Germany, 23 April 2024: AMSilk GmbH (“AMSilk”), a global leader in advanced materials made from spider silk-based proteins, today announces the appointments of Ralph Fraundorfer and Ctibor Kohutovic to its Management Board starting immediately. Read more…

Read more

Futura Medical plc – Appointment of Roy Davis as Non-Executive Director

/in

Futura Medical plc (AIM: FUM) (“Futura” or the “Company”), the pharmaceutical company developing innovative sexual health products, today announces the appointment of Roy Davis as a Non-Executive Director with immediate effect. Read more…

Read more

Versameb AG Names Dr. Alexandre LeBeaut as Chair of the Board of Directors

/in

Versameb AG (“Versameb”), a pre-clinical stage company focused on transforming RNA therapeutics to treat unmet medical needs, today announced that its Board of Directors has unanimously appointed of Dr. Alexandre LeBeaut, MD as Chairman of the Board, effective immediately. Dr. LeBeaut has over two decades of global R&D leadership experiences, successfully bringing multiple medicines to […]

Read more